These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 18332610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S, Ozcan MA, Ateş H, Gürler O, Alacacioglu I, Ozsan GH, Akkoç N, Ozkan S, Demirkan F, Onen F.
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [Abstract] [Full Text] [Related]

  • 4. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A, Ricart J, Todolí J, Micó L, Contreras T, Aznar J.
    Clin Hemorheol Microcirc; 2004 Oct; 30(3-4):411-4. PubMed ID: 15258375
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
    Labiós M, Martínez M, Gabriel F, Guiral V, Ruiz-Aja S, Aznar J.
    Thromb Res; 2006 Oct; 117(4):403-9. PubMed ID: 16461073
    [Abstract] [Full Text] [Related]

  • 7. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
    Ricart JM, Vayá A, Todolí J, Santaolaria ML, Calvo J, Aznar J.
    Clin Hemorheol Microcirc; 2005 Oct; 33(4):389-96. PubMed ID: 16317248
    [Abstract] [Full Text] [Related]

  • 8. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I, Choudhury A, Patel J, Lip GY.
    Ann Med; 2009 Oct; 41(1):45-51. PubMed ID: 18618353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Homocysteine: an activity marker in Behçet's disease?
    Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N.
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [Abstract] [Full Text] [Related]

  • 11. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S, Ricart JM, Medina P, Vayá A, Villa P, Todolí J, Estellés A, Micó ML, Aznar J, España F.
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [Abstract] [Full Text] [Related]

  • 12. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF, Elghoroury EA, Helmy A.
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [Abstract] [Full Text] [Related]

  • 13. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.
    Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS.
    J Am Coll Cardiol; 2005 May 03; 45(9):1467-71. PubMed ID: 15862420
    [Abstract] [Full Text] [Related]

  • 14. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
    Labiós M, Martínez M, Gabriel F, Guiral V, Aznar J.
    Thromb Res; 2006 May 03; 118(4):447-53. PubMed ID: 16242179
    [Abstract] [Full Text] [Related]

  • 15. Decreased erythrocyte deformability in Behçet's disease.
    Usküdar O, Erdem A, Demiroğlu H, Dikmenoğlu N.
    Clin Hemorheol Microcirc; 2005 May 03; 33(2):89-94. PubMed ID: 16151256
    [Abstract] [Full Text] [Related]

  • 16. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB, Wardrop KJ, Meyers KM.
    Am J Vet Res; 2006 Jan 03; 67(1):56-63. PubMed ID: 16426212
    [Abstract] [Full Text] [Related]

  • 17. Platelet activation in acute, decompensated congestive heart failure.
    Chung I, Choudhury A, Lip GY.
    Thromb Res; 2007 Jan 03; 120(5):709-13. PubMed ID: 17287016
    [Abstract] [Full Text] [Related]

  • 18. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
    Bonomini M, Sirolli V, Dottori S, Amoroso L, Di Liberato L, Arduini A.
    Nephrol Dial Transplant; 2007 Sep 03; 22(9):2623-9. PubMed ID: 17478491
    [Abstract] [Full Text] [Related]

  • 19. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J, Jeske WP, Baltasar F, Cornelli U, Manoni M, Hoppensteadt DA, Fareed J.
    Clin Appl Thromb Hemost; 2006 Jul 03; 12(3):311-7. PubMed ID: 16959684
    [Abstract] [Full Text] [Related]

  • 20. [Vascular symptoms of Behcet's disease].
    Alekberova ZS, Elonakov AV, Mach ES, Guseva IA.
    Ter Arkh; 2005 Jul 03; 77(5):39-41. PubMed ID: 15989001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.